Cancer Vaccine Side News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The addition of a personalized cancer vaccine to Keytruda led to a 44% reduction in the risk of death or recurrence in certain patients with melanoma.

United statesRyan sullivanJeffreys weberGrossman school of medicineHarvard medical schoolCancer centerLangone perlmutter cancer centerVaccine decreases deathPerlmutter cancer centerIsaac perlmutter professorTumor mutationMassachusetts general cancer centerResearchers areSupport cancer vaccinesCancer vaccine sideSkin cancer